AKAN on Nasdaq

AKANDA CORP.

Price unavailable

Last updated Oct 16, 2026.

Overview

Compare with Adia Med, Inc., TFA Therapeutics, Inc. or China Foods Holdings Ltd., or pick any stock.

  • TickerAKAN on Nasdaq
  • IndustryMedicinal Chemicals & Botanical Products
  • HeadquartersA6
  • Incorporated inOntario, Canada2
  • Business address1A, 1B Learoyd Road, New Romney, X0 Tn28 8Xu2
  • Filer category, Emerging growth company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

24.9%Gross margin3
-523.8%Operating margin3
-489.6%Net margin3
97.5%Revenue growth, 20243
-95.8%Return on equity3
-$6.1MFree cash flow3

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Infrastructure brought in 50% of the revenue AKANDA CORP. broke down this way in fiscal 2025.

  1. Infrastructure$258.1K450%
  2. Reportable segments [member]$258.1K450%
Business segments by year
Business segments2025
Infrastructure$258.1K
Reportable segments [member]$258.1K

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Other costs100¢$836.7K

Out of $836.7K in revenue.3 The company lost money this year.

Financial statements

Revenue563$836.7K in 2024+40475% since 2020
0$1.0M$2.0M$3.0M2020: $2.1K$2.1K20202021: $41.4K$41.4K2021+1909%2022: $2.6M$2.6M2022+6223%2023: $423.7K$423.7K2023−84%2024: $836.7K$836.7K2024+97%
Gross profit563$208.4K in 2024
-$1.0M0$1.0M$2.0M$3.0M$4.0M2020: -$58.2K-$58.2K20202021: -$1.6K-$1.6K2021−97%2022: $3.3M$3.3M20222023: $59.3K$59.3K2023−98%2024: $208.4K$208.4K2024+251%
Operating income563-$4.4M in 2024+386% since 2019
-$30.0M-$20.0M-$10.0M02019: -$901.2K-$901.2K20192020: -$1.7M-$1.7M2020+85%2021: -$2.6M-$2.6M2021+54%2022: -$20.2M-$20.2M2022+685%2023: -$3.7M-$3.7M2023−82%2024: -$4.4M-$4.4M2024+20%
Net income563-$4.1M in 2024+194% since 2019
-$40.0M-$30.0M-$20.0M-$10.0M02019: -$1.4M-$1.4M20192020: -$2.3M-$2.3M2020+65%2021: -$8.1M-$8.1M2021+253%2022: -$11.7M-$11.7M2022+43%2023: -$32.3M-$32.3M2023+177%2024: -$4.1M-$4.1M2024−87%

Every line of the income statement in the latest annual report, as filed.4

Period ending2025-12-312024-12-31
Sales$258.1K
Cost of sales$414.1K
Gross Profit (Loss)-$156.0K
Depreciation and amortization$433.7K$137.3K
Consulting and professional fees$1.5M$2.4M
Personnel expenses$624.7K$495.7K
General and administrative expenses$2.3M$1.0M
Total operating expenses$4.8M$4.0M
Operating loss-$5.0M-$4.0M
Finance income$3.0K
Finance expense-$925.1K-$81.1K
Foreign exchange gain (loss), net$273.6K-$132.8K
Transaction costs-$350.0K
Change in fair value of financial liabilities measured at FVTPL$1.8M
Gain (loss) on debt settlement$1.9M-$219.7K
Other income$74.5K
Gain on sale of subsidiary$198.8K
Write-off of AP, net$475.8K
Write-off of holdback payable$400.0K
Write-off of loan receivable-$235.7K
Impairment loss-$44.8M
Total Other income-$42.4M$718.4K
Net loss from continuing operations-$47.4M-$3.3M
Gain (loss) from discontinued operation$507.6K-$784.2K
Net loss-$46.9M-$4.1M
Translation adjustment-$175.7K-$101.2K
Shareholders of the Company-$45.7M-$4.1M
Non-controlling interest-$1.2M
Shareholders of the Company-$46.2M-$4.2M
Non-controlling interest-$792.7K
Net comprehensive loss attributable-$47.0M-$4.2M
Loss per share from continuing operations basic (in Dollars per share)-$669.58-$223.48
Loss per share from continuing operations diluted (in Dollars per share)-$669.58-$223.48
Loss per share basic (in Dollars per share)-$662.22-$276.40
Loss per share diluted (in Dollars per share)-$662.22-$276.40
Weighted average common shares outstanding (in Shares)68.9K shares14.8K shares

Compare AKANDA CORP. with another company

Recent filings

  1. Oct 1, 2026F-1 REGISTRATION STATEMENT
  2. Sep 30, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
  3. Sep 25, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
  4. Sep 9, 20266-K
  5. Sep 4, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
  6. Aug 17, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
  7. Aug 13, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
  8. Jun 18, 20266-K
  9. Jun 12, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
  10. Jun 9, 202620-F ANNUAL REPORT
  11. May 22, 20266-K CURRENT REPORT
  12. May 13, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
  13. May 1, 2026NT 20-F NOTIFICATION OF LATE FILING
  14. Apr 29, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
  15. Apr 10, 20266-K REPORT OF FOREIGN PRIVATE ISSUER

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6